Der-yuan S. Chen

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 221 publications

Risk of falls, recurrent falls and osteoporotic fractures in SLE patients with comorbid fibromyalgia: a propensity score-matched cohort study using the TriNetX Network.

Risk of falls, recurrent falls and osteoporotic fractures in SLE patients with comorbid fibromyalgia: a propensity score-matched cohort study using the TriNetX Network.

Journal: Lupus science & medicine
Published: June 01, 2026

Longitudinal Trajectories and Predictors of Health-Related Quality of Life in Systemic Lupus Erythematosus: A 2-Year Longitudinal Cohort Study.

Longitudinal Trajectories and Predictors of Health-Related Quality of Life in Systemic Lupus Erythematosus: A 2-Year Longitudinal Cohort Study.

Journal: Rheumatology and therapy
Published: March 22, 2026

Elevated Subfraction 5 of Low-Density Lipoprotein Cholesterol in Patients With Antiphospholipid Antibody Syndrome.

Elevated Subfraction 5 of Low-Density Lipoprotein Cholesterol in Patients With Antiphospholipid Antibody Syndrome.

Journal: International journal of rheumatic diseases
Published: January 12, 2026

Metabolic Syndrome and Metabolic Dysfunction-associated Steatotic Liver Disease in Fibromyalgia.

Metabolic Syndrome and Metabolic Dysfunction-associated Steatotic Liver Disease in Fibromyalgia.

Journal: Archives of rheumatology
Published: December 01, 2025

FTO rs7195994 Is associated with TNF inhibitor response in lean rheumatoid arthritis patients: A BMI-stratified pharmacogenetic analysis.

FTO rs7195994 Is associated with TNF inhibitor response in lean rheumatoid arthritis patients: A BMI-stratified pharmacogenetic analysis.

Journal: The pharmacogenomics journal
Published: October 14, 2025

Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case-Control Study.

Mandatory Biological/Targeted Synthetic Disease-Modifying Antirheumatic Drugs Dose Reduction on Risk of Serious Infections in Patients with Rheumatoid Arthritis: A Nationwide Nested Case-Control Study.

Journal: Biomedicines
Published: September 26, 2025

Aggravated effects of human parvovirus B19 NS1 protein on bleomycin‑induced pulmonary fibrosis.

Aggravated effects of human parvovirus B19 NS1 protein on bleomycin‑induced pulmonary fibrosis.

Journal: Molecular medicine reports
Published: September 13, 2025

Amorphous calcium carbonate supplementation and bone outcomes in rheumatoid arthritis: A prospective cohort study.

Amorphous calcium carbonate supplementation and bone outcomes in rheumatoid arthritis: A prospective cohort study.

Journal: Medicine
Published: August 20, 2025

Age-related patterns of organ damage impact on health-related quality of life in SLE.

Age-related patterns of organ damage impact on health-related quality of life in SLE.

Journal: Lupus science & medicine
Published: May 19, 2025

A panel incorporating genetic variants of RIN3, NLRC3, and SLX4 shows promise in predicting remission after tofacitinib therapy in rheumatoid arthritis patients.

A panel incorporating genetic variants of RIN3, NLRC3, and SLX4 shows promise in predicting remission after tofacitinib therapy in rheumatoid arthritis patients.

Journal: Clinical and experimental rheumatology
Published: May 19, 2025

Extracellular Vesicle-Delivered tRF-His-GTG-1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID-19.

Extracellular Vesicle-Delivered tRF-His-GTG-1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID-19.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 14, 2025

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.

Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.

Journal: Therapeutic advances in musculoskeletal disease
Published: May 13, 2025
Showing 1-12 of 221

Last Updated: 09/26/2026